Tracking Biological Responses to Lifestyle Changes in AMD Patients

This study examines how blood and fecal biomarkers related to age-related macular degeneration (AMD) respond to lifestyle changes, aiming to identify measurable health improvements.

Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults. Lifestyle factors like diet, smoking, and exercise impact AMD risk, but motivating change is challenging. This project uses biomarkers from blood and stool to show how lifestyle changes reduce AMD progression risk. We will analyze data from over 13,000 participants, linking biomarkers to lifestyle and AMD outcomes. This research aims to create tools that predict risk, provide personalized feedback, and empower patients to make changes, ultimately preventing vision loss and reducing healthcare burdens.

This project is innovative because it analyzes a comprehensive set of biomarkers from both blood and fecal samples, giving AMD patients feedback on how lifestyle changes impact both overall health and disease progression. By focusing on a large number of biomarkers, we can capture biological responses that reflect how lifestyle modifications can slow AMD progression. This approach empowers patients to actively participate in their care, using concrete information to make informed choices that may positively influence their disease trajectory and quality of life.

Results from this study could identify biomarkers that indicate positive responses to lifestyle changes in AMD patients, motivating sustained healthy habits. By showing how small changes can lead to measurable biological improvements, we aim to empower patients to take an active role in managing their disease. The findings may also offer new targets for interventions and help refine personalized treatment strategies in AMD care, potentially slowing disease progression and improving quality of life.